Etiologic theories of chronic prostatitis/chronic pelvic pain syndrome

Current Urology Reports

Volumn 8, Issue 4, 2007, Pages 307-312

  Pontari, Michel A ^a  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; EDETIC ACID; QUERCETIN; TETRACYCLINE;

AUTOIMMUNITY; BACTERIAL INFECTION; CELL PROLIFERATION; CHRONIC PROSTATITIS; CYTOKINE PRODUCTION; DNA POLYMORPHISM; DNA SEQUENCE; EVIDENCE BASED MEDICINE; GENETIC PREDISPOSITION; GENETIC VARIABILITY; HUMAN; MENTAL STRESS; NEUROGENIC INFLAMMATION; NONHUMAN; PATHOGENESIS; PELVIS PAIN SYNDROME; POLYMERASE CHAIN REACTION; PROSTATE DISEASE; PROSTATE SECRETION; PROSTATE STONE; PSYCHOLOGICAL ASPECT; REVIEW; SEXUAL BEHAVIOR; STIMULUS RESPONSE;

CHRONIC DISEASE; HUMANS; MALE; PELVIC PAIN; PROSTATITIS; SYNDROME;

EID: 34547430591     PISSN: 15272737     EISSN: 15346285     Source Type: Journal    
DOI: 10.1007/s11934-007-0077-6     Document Type: Review

References (44)

1. Weidner W, Schiefer HG, Krauss H, et al.: Chronic prostatitis: a thorough search for etiologically involved microorganisms in 1,461 patients. Infection 1991, 19:S119-S125.
2. Nickel JC: Prostatitis syndromes: an update for urologic practice. Can J Urol 2000, 7:1091-1098.
3. Pontari MA, McNaughton-Collins M, O'Leary MP, et al.: A case-control study of risk factors in men with chronic pelvic pain syndrome. BJU Int 2005, 96:559-565.
4. Alexander R, Ponniah S, Hasday J, et al.: Elevated levels of proinflammatory cytokines in the semen of patients with chronic prostatitis/chronic pelvic pain syndrome. Urology 1998, 52:744-749.
5. Doble A, Thomas BJ, Walker MM, et al.: The role of Chlamydia trachomatis in chronic abacterial prostatitis: a study using ultrasound guided biopsy. J Urol 1989, 141:332-333.
6. Schneider H, Ludwig M, Hossain HM, et al.: The 2001 Giessen Cohort Study on patients with prostatitis syndrome: an evaluation of inflammatory status and search for microorganisms 10 years after a first analysis. Andrologia 2003, 35:258-262.
7. Mehik A, Hellstrom P, Lukkarinen O, et al.: Epidemiology of prostatitis in Finnish men: a population-based cross-sectional study. BJU Int 2000, 86:443-448.
8. Collins MM, Meigs JB, Barry MJ, et al.: Prevalence and correlates of prostatitis in the health professionals follow-up study cohort. J Urol 2002, 167:1363-1366.
9. Leskinen MJ, Rantakokko-Jalava K, Manninen R, et al.: Negative bacterial polymerase chain reaction (PCR) findings in prostate tissue from patients with symptoms of chronic pelvic pain syndrome (CPPS) and localized prostate cancer. Prostate 2003, 55:105-110.
10. Leskinen MJ, Vainionp R, Syrjnen S, et al.: Herpes simplex virus, cytomegalovirus, and papillomavirus DNA are not found in patients with chronic pelvic pain syndrome undergoing radical prostatectomy for localized prostate cancer. Urology 2003, 61:397-401.
11. Lee JC, Muller CH, Rothman I, et al.: Prostate biopsy culture findings of men with chronic pelvic pain syndrome do not differ from those of healthy controls. J Urol 2003, 169:584-587.
12. Nickel JC, Alexander RB, Schaeffer AJ, et al.: Leukocytes and bacteria in men with chronic prostatitis/chronic pelvic pain syndrome compared to asymptomatic controls. J Urol 2003, 170:818-822. Large series of men with CP/CPPS compared with a group of age-matched controls, comparing leukocytes in semen, prostate fluid and urine, and bacterial localization studies.
13. Shahed AR, Shoskes DA: Oxidative stress in prostatic fluid of patients with chronic pelvic pain syndrome: correlation with gram positive bacterial growth and treatment response. J Androl 2000, 21:669-675.
14. Torres Ramirez C, Aguilar Ruiz J, Zuluaga Gomez A, et al.: [Structure of primary prostatic endogenous calculi]. Arch Esp Urol 1979, 32:581-590.
15. Shoskes DA, Thomas KD, Gomez E: Anti-nanobacterial therapy for men with chronic prostatitis/chronic pelvic pain syndrome and prostatic stones: preliminary experience. J Urol 2005, 173:474-477.
16. Pacheco-Rupil B, Depiante-Depaoli M, Casadio B: Experimental autoimmune damage to rat male accessory glands. II. T cell requirement in adoptive transfer of specific tissue damage. Am J Reprod Immunol 1984, 5:15-19.
17. Donadio AC, Depiante-Depaoli M: Inflammatory cells and MHC class II antigens expression in prostate during time-course experimental autoimmune prostatitis development. Clin Immunol Immunopathol 1997, 85:158-165.
18. Casas-Ingaramo A, Depiante-Depaoli M, Pacheco-Rupil B: Activation of cytotoxic cells by syngeneic prostate antigens in experimental autoimmune vesiculo-prostatitis. Autoimmunity 1991, 9:151-157.
19. Keetch DW, Humphrey P, Ratliff TL: Development of a mouse model for nonbacterial prostatitis. J Urol 1994, 52:247-250.
20. Alexander RB, Brady F, Ponniah S: Autoimmune prostatitis: evidence of T cell reactivity with normal prostatic proteins. Urology 1997, 50:893-899.
21. Ponniah S, Arah I, Alexander RB: PSA is a candidate self-antigen in autoimmune chronic prostatitis/chronic pelvic pain syndrome. Prostate 2000, 44:49-54.
22. Batstone GR, Doble A, Gaston JS: Autoimmune T cell responses to seminal plasma in chronic pelvic pain syndrome (CPPS). Clin Immunol Immunopathol 2002, 128:302-307.
23. Dunphy EJ, Eickhoff JC, Muller CH, et al.: Identification of antigen-specific IgG in sera from patients with chronic prostatitis. J Clin Immunol 2004, 24:492-502.
24. Scanlan MJ, Chen YT, Williamson B, et al.: Characterization of human colon cancer antigens recognized by autologous antibodies. Int J Cancer 1998, 76:652-658.
25. Ochs RL, Stein TW Jr, Chan EK, et al.: cDNA cloning and characterization of a novel nucleolar protein. Mol Biol Cell 1996, 7:1015-1024.
26. Fossa A, Siebert R, Aasheim HC, et al.: Identification of nucleolar protein No55 as a tumour-associated autoantigen in patients with prostate cancer. Br J Cancer 2000, 83:743-749.
27. Ishigooka M, Zermann DH, Doggweiler R, Schmidt RA: Similarity of distributions of spinal c-Fos and plasma extravasation after acute chemical irritation of the bladder and the prostate. J Urol 2000, 164:1751-1756.
28. Keith IM, Jin J, Neal D Jr, et al.: Cell relationship in a Wistar rat model of spontaneous prostatitis. J Urol 2001, 166:323-328.
29. Zermann DH, Ishigooka M, Doggweiler R, Schmidt RA: Neurourological insights into the etiology of genitourinary pain in men. J Urol 1999, 161:903-908.
30. Yang CC, Lee JC, Kromm BG, et al.: Pain sensitization in male chronic pelvic pain syndrome: why are symptoms so difficult to treat? J Urol 2003, 170:823-826. Study documenting differences in sensory function in men with CP/CPPS, supporting the idea that there are neurologic changes that have occurred in these patients.
31. Nickel JC, Berger RE, Pontari MA: Chronic pelvic pain: new pathways to discovery. Rev Urol 2006, 8:28-35.
32. Kroeger KM, Carville KS, Abraham LJ: The -308 tumor necrosis factor-alpha promoter polymorphism effects transcription. Mol Immunol 1997, 34:391-399.
33. Turner DM, Williams DM, Sankaran D, et al.: An investigation of polymorphism in the interleukin-10 gene promoter. Eur J Immunogenet 1997, 24:1-8.
34. Shoskes DA, Albakri Q, Thomas K, Cook D: Cytokine polymorphisms in men with chronic prostatitis/chronic pelvic pain syndrome: association with diagnosis and treatment response. J Urol 2002, 168:331-335.
35. Riley DE, Krieger JN: X Chromosomal short tandem repeat polymorphisms near the phosphoglycerate kinase gene in men with chronic prostatitis. Biochim Biophys Acta 2002, 1586:99-107.
36. Riley DE, Krieger JN: Diverse eukaryotic transcripts suggest short tandem repeats have cellular functions. Biochem Biophys Res Commun 2002, 298:581-586.
37. Mehik A, Hellstrom P, Sarpola A, et al.: Fears, sexual disturbances and personality features in men with prostatitis: a population-based cross-sectional study in Finland. BJU Int 2001, 88:35-38.
38. Ware JE, Kosinski M, Keller SD: A 12-Item Short Form Health Survey: construction of scales and preliminary tests of reliability and validity. Med Care 1996, 34:220-223.
39. McNaughton Collins M, Pontari MA, O'Leary MP, et al.: Quality of life is impaired in men with chronic prostatitis: the Chronic Prostatitis Collaborative Research Network. J Gen Intern Med 2001, 16:656-662.
40. Spanos C, Pang X, Ligris K, et al.: Stress-induced bladder mast cell activation: implications for interstitial cystitis. J Urol 1997, 157:669-672.
41. Miller LJ, Fischer KA, Goralnick SJ, et al.: Nerve growth factor and chronic prostatitis/chronic pelvic pain syndrome. Urology 2002, 59:603-608.
42. Ullrich PM, Turner JA, Ciol M, Berger R: Stress is associated with subsequent pain and disability among men with nonbacterial prostatitis/pelvic pain. Ann Behav Med 2005, 30:112-118. This study documents the common clinical observation that symptoms of CP/CPPS are related to or exacerbated by stress.
43. Weissman MM, Gross R, Fyer A, et al.: Interstitial cystitis and panic disorder: a potential genetic syndrome. Arch Gen Psychiatry 2004, 61:273-279.
44. de la Rosette JJ, Hubregtse MR, Meuleman EJ, et al.: Diagnosis and treatment of 409 patients with prostatitis syndromes. Urology 1993, 41:301-307.